Praxis Precision Medicines, Inc. PRAX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $536.75M+223% | $357.75M+65.8% | $149.94M-11.3% | $157.83M+8.4% | $165.98M+8.9% | ||
| $250.53M+54.2% | $242M+36.6% | $117.63M-37.6% | $143.86M— | $162.42M— | ||
| —— | —— | —— | —— | —— | ||
| $34.48M+36.6% | $29.16M+21.2% | $29.38M+85.7% | $25.71M+70.9% | $25.24M+60.4% | ||
| $250.53M+54.2% | $242M+36.6% | $117.63M-37.6% | $143.86M— | $162.42M— | ||
| $797.77M+139% | $610.91M+51.1% | $273.84M-23.9% | $306.58M-14.1% | $333.58M+57.5% | ||
| $170K-31.2% | $147K-36.1% | $174K-37.2% | $258K-30.1% | $247K-48.1% | ||
| $1.32M+49.7% | $92K-91.9% | $362K-73.7% | $626K-61.1% | $882K-52.1% | ||
| $660.94M+359% | $326.76M+325% | $122.01M+125% | $145.37M— | $144.03M— | ||
| $1.46B+205% | $937.91M+94.1% | $396.39M-4.8% | $452.83M+2.7% | $478.74M+91.2% | ||
| $31.16M+36.0% | $24.63M+96.6% | $30.82M+105% | $28.83M+252% | $22.91M+144% | ||
| $17.65M+13.5% | $35.03M+47.4% | $21.63M+39.9% | $19.02M+89.1% | $15.55M+123% | ||
| $1.44M+34.6% | $110K-91.3% | $436K-64.4% | $755K-36.6% | $1.07M-7.9% | ||
| $50.24M+27.1% | $59.77M+59.2% | $52.88M+60.9% | $48.61M+136% | $39.52M+110% | ||
| —— | —— | —— | —— | —— | ||
| $50.24M+27.1% | $59.77M+58.7% | $52.88M+57.4% | $48.61M+121% | $39.52M+90.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 150M0.0% | 150M+1,071,329% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| $2.64B+96.6% | $2.02B+57.4% | $1.39B+20.2% | $1.38B+20.6% | $1.34B+45.7% | ||
| -$1.23B-36.0% | -$1.14B-36.2% | -$1.05B-35.1% | -$977.16M-34.6% | -$906.04M-30.7% | ||
| -$1.59M-342% | $563K-13.9% | $500K-62.4% | $395K+656% | $659K+21,867% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $1.41B+221% | $878.14M+97.1% | $343.51M-10.2% | $404.22M-3.5% | $439.21M+91.2% | ||
| $1.46B+205% | $937.91M+94.1% | $396.39M-4.8% | $452.83M+2.7% | $478.74M+91.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.32M+49.7% | $92K-91.9% | $362K-73.7% | $626K-61.1% | $882K-52.1% | ||
| $911.47M+533% | $568.76M+639% | $122.01M+125% | $145.37M— | $144.03M— | ||
| —— | —— | —— | —— | —— | ||
| $1.32M+49.7% | $92K-91.9% | $362K-73.7% | $626K-61.1% | $882K-52.1% | ||
| $1.32M+49.7% | $92K-91.9% | $362K-73.7% | $626K-61.1% | $882K-52.1% | ||
| $17.65M+13.5% | $35.03M+47.4% | $21.63M+39.9% | $19.02M+89.1% | $15.55M+123% | ||
| $17.65M+13.5% | $35.03M+47.4% | $21.63M+39.9% | $19.02M+89.1% | $15.55M+123% | ||
| $1.4M+31.3% | $110K-92.0% | $436K-73.7% | $755K-61.2% | $1.07M-52.1% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 27.9M+37.0% | 25.2M+29.7% | 21.2M+19.0% | 21M+18.5% | 20.3M+53.4% | ||
| —— | —— | —— | —— | —— | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $15K+7.1% | $15K+7.1% | $14K0.0% | $14K0.0% | $14K+7.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 1.9M-5.1% | 1.9M+3.7% | 2.1M+13.2% | 2.1M+85.3% | 2.1M+89.1% | ||
| 6.7M+27.3% | 5.3M+53.2% | 5.2M+48.2% | 5.2M+48.7% | 5.3M+33.5% | ||
| $101.08+15.1% | $89.80-1.1% | $87.20-3.2% | $86.63-21.8% | $87.82-23.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $12.94M+11.2% | $14.29M+6.9% | $15.62M+32.9% | $15.28M+108% | $11.64M+147% | ||
| $2.99M+39.2% | $18.71M+99.8% | $3.68M+16.5% | $2.63M+27.3% | $2.15M+29.3% | ||
| $660.94M+359% | $326.76M+325% | $122.01M+125% | $145.37M— | $144.03M— | ||
| $250.53M+54.2% | $242M+36.6% | $117.63M-37.6% | $143.86M— | $162.42M— | ||
| $1.16B+189% | $771.06M+93.4% | $315.67M— | $375.58M— | $400.5M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.16B+190% | $770.49M+93.5% | $315.17M— | $375.19M— | $399.84M— | ||
| $6.73M+27.3% | $5.32M+53.2% | $5.22M+48.2% | $5.24M+48.7% | $5.28M+33.5% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $150M0.0% | $150M0.0% | $150M0.0% | $150M0.0% | $150M0.0% | ||
| $27.86M+37.0% | $25.2M+29.7% | $21.17M+19.0% | $21.04M+18.5% | $20.34M+53.4% | ||
| $27.86M+37.0% | $25.2M+29.7% | $21.17M+19.0% | $21.04M+18.5% | $20.34M+53.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.72M-2.6% | $2.03M+96.0% | $2.32M+331% | $1.11M+73.8% | $1.76M+194% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.95M-5.1% | $1.88M+3.7% | $2.07M+13.2% | $2.1M+85.3% | $2.05M+89.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $101.08+15.1% | $89.8-1.1% | $87.2-3.2% | $86.63-21.8% | $87.82-23.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Praxis Precision Medicines, Inc.'s total assets?
- Praxis Precision Medicines, Inc. (PRAX) holds $1.5B in total assets, up 205.0% year over year.
- How much debt does Praxis Precision Medicines, Inc. have?
- Praxis Precision Medicines, Inc. carries $1.4M in total debt against $1.4B of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Praxis Precision Medicines, Inc. have?
- Praxis Precision Medicines, Inc. holds $536.7M in cash and equivalents.
- Can Praxis Precision Medicines, Inc. cover its short-term obligations?
- Its current ratio is 15.88 — current assets exceed current liabilities.
- Where does Praxis Precision Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.